XML 52 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
May. 31, 2015
May. 25, 2014
May. 26, 2013
Consolidated net income $ 13,725,000 $ 19,342,000 $ 22,812,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,090,000 7,114,000 7,295,000
Stock-based compensation expense 1,577,000 1,356,000 1,695,000
Deferred taxes 4,152,000 5,585,000 6,606,000
Change in investment in non-public company , fair value (3,900,000) (10,000,000) (8,100,000)
Tax benefit from stock based compensation (463,000) $ (1,922,000) $ (1,302,000)
Impairment of non-public company, non-fair value investment 793,000    
Net loss (gain) on disposal of property and equipment $ (90,000) $ 329,000 $ 217,000
Earn out liability     (3,933,000)
Changes in assets and liabilities, net of effects from acquisitions:      
Accounts receivable, net $ (1,752,000) $ (7,994,000) (4,121,000)
Accounts receivable, related party (2,000) 12,000 (348,000)
Income taxes receivable 2,313,000 5,025,000 (3,754,000)
Inventories, net (292,000) (622,000) (2,102,000)
Issuance of notes and advances receivable (5,691,000) (4,763,000) (4,173,000)
Collection of notes and advances receivable 5,730,000 4,481,000 4,173,000
Prepaid expenses and other current assets (2,175,000) (32,000) (278,000)
Accounts payable 2,784,000 (50,000) 8,826,000
Accounts payable, related party 110,000 $ (91,000) $ 10,000
Income taxes payable 1,229,000    
Accrued compensation 2,646,000 $ 38,000 $ (798,000)
Other accrued liabilities (1,218,000) 3,211,000 (2,486,000)
Deferred revenue (411,000) 6,000 1,086,000
Net cash provided by operating activities 26,155,000 21,045,000 21,230,000
Cash flows from investing activities:      
Purchases of property and equipment (17,511,000) $ (14,886,000) $ (8,877,000)
Investment in non-public company, fair value (18,000,000)    
Proceeds from sale of fixed assets $ 1,071,000    
Purchase of marketable securities   $ (1,417,000) $ (4,959,000)
Proceeds from maturities of marketable securities   2,962,000 3,414,000
Net cash used in investing activities $ (34,440,000) (13,341,000) (10,422,000)
Cash flows from financing activities:      
Proceeds from sale of common stock 122,000 2,298,000 3,416,000
Taxes paid by Company for stock swaps and RSUs (343,000) (1,271,000) (49,000)
Tax benefit from stock-based compensation expense $ 463,000 $ 1,922,000 1,302,000
Earn out payment from Lifecore acquisition     (9,650,000)
Net change in other assets/liabilities $ (24,000) $ 31,000 $ 712,000
Proceeds from long term debt 15,014,000    
Payments on long term debt (6,867,000) $ (5,933,000) $ (7,012,000)
Proceeds from lines of credit 30,417,000 9,500,000  
Payments on lines of credit (30,417,000) (13,500,000) $ (7,666,000)
Payments to non-controlling interest. (196,000) (226,000) (320,000)
Net cash (used in) provided by financing activities 8,169,000 (7,179,000) (19,267,000)
Net increase (decrease) in cash and cash equivalents (116,000) 525,000 (8,459,000)
Cash and cash equivalents at beginning of year 14,243,000 13,718,000 22,177,000
Cash and cash equivalents at end of year 14,127,000 14,243,000 13,718,000
Supplemental disclosure of cash flows information:      
Cash paid during the period for interest 1,994,000 1,504,000 1,728,000
Cash paid during the period for income taxes, net of refunds received $ 150,000 $ 50,000 $ 5,605,000